Performance of the 2017 EULAR/ACR classification criteria in anti ‐MDA5 associated idiopathic inflammatory myopathy

ConclusionsAlmost 30% of patients with clinical anti-MDA5 associated IIM could not be classified by the EULAR/ACR criteria. Modification of the existing criteria incorporating anti-MDA5 antibody or development of a new specific set of criteria for “anti-MDA5 syndrome” are suggested.

Source: Arthritis and Rheumatology - April 25, 2022 Category: Rheumatology Authors: Ho So, Jacqueline So, Tommy Tsz ‐On Lam, Victor Tak‐Lung Wong, Roy Ho, Wai Ling Li, Chi Chiu Mok, Chak Sing Lau, Lai‐Shan Tam Tags: Brief Report Source Type: research